Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
K
Kinnevik
Activity from announced rounds
All recorded activity
- Rounds participated in
- 6
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $951M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in all activityEnveda
$311MSeries E
ParticipantTandem Health
Tandem builds an AI clinical assistant that turns patient consultations and clinician dictation into draft notes and follow-up documents for review in existing medical-record systems.
$100MSeries B
ParticipantAnterior
Anterior helps health insurers and delegated care organizations apply clinical AI to prior authorization, utilization management and other payer workflows.
$40MUndisclosed
Role not disclosedMews
Mews provides hospitality software for revenue and operational workflows.
$300MSeries D
Role not disclosedOviva
Reimbursed digital care combining a clinical app and specialist teams for obesity and chronic conditions.
UndisclosedSeries D
LeadPerk
Software for booking business travel and managing company expenses.
$200MSeries E
Participant